speb/financial-data huggingface dataset:
Financial ratios for CDT — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3616000
Net income: -4753000
Capital expenditures: 404000
Operating cash flow: -3929000
Depreciation & amortization: 197000
Net tangible assets: 2687000
Owner earnings: -4960000
Return on net tangible assets (%): -184.59248232229254
Buffett classification: The Gruesome
Stock price: 23430
Shares outstanding: 631077
Book value: 2687000
P/B ratio: 5502.841127651656
Market cap (USD): 14786134110
Debt to equity: 1.0669892072943803
Current ratio: 1.3080474934036939
Quick ratio: 1.3080474934036939
Interest coverage ratio: -20.545454545454547
Free cash flow (dilution-adjusted): -4567000
Buyback yield (%): 0
Retained earnings: -34247000
Receivables turnover: 0
Capitalized R&D asset: 1004440
ROCI (R&D-adjusted, %): -80.72486481144196
Rule of 40 score: 0
Financial ratios for CDT — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -4952000
Net income: -6028000
Capital expenditures: 1000
Operating cash flow: -2580000
Depreciation & amortization: 828000
Net tangible assets: 3529000
Owner earnings: -5201000
Return on net tangible assets (%): -147.37886086710117
Buffett classification: The Gruesome
Stock price: 5520
Shares outstanding: 631077
Book value: 3529000
P/B ratio: 987.1195919523946
Market cap (USD): 3483545040
Debt to equity: 0.5854349674128648
Current ratio: 1.4470881486517109
Quick ratio: 1.4470881486517109
Interest coverage ratio: -86.87719298245614
Free cash flow (dilution-adjusted): -2741000
Buyback yield (%): 0
Retained earnings: -39882000
Receivables turnover: 0
Capitalized R&D asset: 2517280
ROCI (R&D-adjusted, %): -66.65266216772139
Rule of 40 score: 0
Financial ratios for CDT — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -6936000
Net income: -7118000
Capital expenditures: 7000
Operating cash flow: -4410000
Depreciation & amortization: 6000
Net tangible assets: 4278000
Owner earnings: -7119000
Return on net tangible assets (%): -166.4095371669004
Buffett classification: The Gruesome
Stock price: 1360
Shares outstanding: 631077
Book value: 4278000
P/B ratio: 200.62288920056102
Market cap (USD): 858264720
Debt to equity: 0.438288920056101
Current ratio: 1.6633059788980071
Quick ratio: 1.6633059788980071
Interest coverage ratio: -144.5
Free cash flow (dilution-adjusted): -6981000
Buyback yield (%): 0
Retained earnings: -47000000
Receivables turnover: 0
Capitalized R&D asset: 3080480
ROCI (R&D-adjusted, %): -92.84042847757985
Rule of 40 score: 0
Financial ratios for CDT — annual report dated 2025-12-31
Total revenue: 0
Operating income: -36660000
Net income: -39224000
Capital expenditures: 405000
Operating cash flow: -15555000
Depreciation & amortization: 2425000
Net tangible assets: -7170000
Owner earnings: -37204000
Buffett classification: The Gruesome
Stock price: 320
Shares outstanding: 631077
Book value: -7170000
Market cap (USD): 201944640
Debt to equity: -0.10808926080892609
Current ratio: 0.34157566302652104
Quick ratio: 0.34157566302652104
Interest coverage ratio: -114.92163009404389
Free cash flow (dilution-adjusted): -20141000
Buyback yield (%): 0.05248963280233632
Retained earnings: -68325000
Capitalized R&D asset: 7346960
ROCI (R&D-adjusted, %): -19465.79264617239
Rule of 40 score: 0
Financial ratios for CDT — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -21156000
Net income: -21325000
Capital expenditures: 7000
Operating cash flow: -4636000
Depreciation & amortization: 2409000
Net tangible assets: -7170000
Owner earnings: -18923000
Buffett classification: The Gruesome
Stock price: 320
Shares outstanding: 631077
Book value: -7170000
Market cap (USD): 201944640
Debt to equity: -0.10808926080892609
Current ratio: 0.34157566302652104
Quick ratio: 0.34157566302652104
Interest coverage ratio: -556.7368421052631
Free cash flow (dilution-adjusted): -5852000
Buyback yield (%): 0
Retained earnings: -68325000
Capitalized R&D asset: 2386240
Rule of 40 score: 0
Financial ratios for CKX — annual report dated 2021-12-31
Capital expenditures: 22669
Buffett classification: The Gruesome
Stock price: 11.2
Shares outstanding: 2053129
Market cap (USD): 22995044.799999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKX — annual report dated 2022-12-31
Total revenue: 1105494
Gross profit: 1014206
Operating income: -1861512
Net income: -1317718
Capital expenditures: 6137
Operating cash flow: 413691
Depreciation & amortization: 5922
Net tangible assets: 17420414
Owner earnings: -1317933
Return on net tangible assets (%): -7.565451659185597
Buffett classification: The Gruesome
Stock price: 9.95
Shares outstanding: 2053129
Book value: 17420414
P/B ratio: 1.1726835854762119
Market cap (USD): 20428633.549999997
Debt to equity: 0
Current ratio: 31.09533790460221
Quick ratio: 31.09533790460221
COGS to revenue (%): 8.257665803704045
SG&A to revenue (%): 260.12967958215967
Free cash flow (dilution-adjusted): -1924142
Buyback yield (%): 0.8644337349719606
Retained earnings: 15229134
Receivables turnover: 8.744405685674284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.685808041071814
FCF margin (%): -174.05268594854425
Rule of 40 score: -174.05268594854425
Financial ratios for CKX — annual report dated 2023-12-31
Total revenue: 1485605
Gross profit: 1422140
Operating income: -28168
Net income: 142961
Capital expenditures: 149992
Operating cash flow: 876953
Depreciation & amortization: 4946
Net tangible assets: 18318058
Owner earnings: -2085
Return on net tangible assets (%): -0.011382210930874877
Buffett classification: The Gruesome
Stock price: 12.96
P/E ratio: 186.12455033190872
Shares outstanding: 2053129
Book value: 18318058
P/B ratio: 1.4525858494388435
Market cap (USD): 26608551.840000004
Debt to equity: 0
Current ratio: 18.95411306798453
Quick ratio: 18.95411306798453
Effective tax rate (%): 49.34071814061608
COGS to revenue (%): 4.271996930543449
SG&A to revenue (%): 97.62406561636506
Free cash flow (dilution-adjusted): 14377
Buyback yield (%): 0.32754882912861294
Retained earnings: 15372095
Receivables turnover: 14.183605273961486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1537717589932295
FCF margin (%): 0.9677538780496835
Revenue growth (%): 34.38381393295667
Rule of 40 score: 35.351567811006355
Financial ratios for CKX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.92
Shares outstanding: 2053129
Market cap (USD): 28579555.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKX — annual report dated 2024-12-31
Total revenue: 1521124
Gross profit: 1451509
Operating income: 31356
Net income: 250224
Capital expenditures: 140582
Operating cash flow: 204761
Depreciation & amortization: 4352
Net tangible assets: 18583054
Owner earnings: 113994
Return on net tangible assets (%): 0.6134298485060636
Capex to operating income (%): 448.3416252072969
Buffett classification: The Gruesome
Stock price: 12.6
P/E ratio: 103.38506857855361
Shares outstanding: 2053129
Book value: 18583054
P/B ratio: 1.3920976283015696
Market cap (USD): 25869425.4
Debt to equity: 0
Current ratio: 36.26042553835788
Quick ratio: 36.26042553835788
Effective tax rate (%): 25.908730205730123
COGS to revenue (%): 4.576549972257357
SG&A to revenue (%): 93.36207962007043
Free cash flow (dilution-adjusted): -18865
Buyback yield (%): 0.8073391533466376
Retained earnings: 15622319
Receivables turnover: 19.4718826405868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1687343748772403
FCF margin (%): -1.2402013248098116
Revenue growth (%): 2.3908777905297844
Rule of 40 score: 1.1506764657199728
Financial ratios for CKX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.6
Shares outstanding: 2053129
Market cap (USD): 25869425.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKX — quarterly report dated 2025-03-31
Total revenue: 348184
Gross profit: 322830
Operating income: 112150
Net income: 115573
Capital expenditures: 0
Operating cash flow: 118664
Depreciation & amortization: 870
Net tangible assets: 18698627
Owner earnings: 116443
Return on net tangible assets (%): 0.622735562349043
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.87
P/E ratio: 52.71698673132998
Shares outstanding: 2053129
Book value: 18698627
P/B ratio: 1.3033385408458065
Market cap (USD): 24370641.229999997
Debt to equity: 0
Current ratio: 37.53426149748264
Quick ratio: 37.53426149748264
Effective tax rate (%): 43.82761352534909
COGS to revenue (%): 7.281782046274383
SG&A to revenue (%): 60.50823702410219
Free cash flow (dilution-adjusted): 118664
Buyback yield (%): 0
Retained earnings: 15737892
Receivables turnover: 5.169079113407266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5997766573984282
FCF margin (%): 34.080830825080994
Rule of 40 score: 34.080830825080994
Financial ratios for CKX — quarterly report dated 2025-06-30
Total revenue: 135936
Gross profit: 121254
Operating income: -29541
Net income: 161042
Capital expenditures: 0
Operating cash flow: -24638
Depreciation & amortization: 817
Net tangible assets: 18712055
Owner earnings: 161859
Return on net tangible assets (%): 0.8649985263510608
Buffett classification: The Gruesome
Stock price: 10.7
P/E ratio: 79.41897691737613
Shares outstanding: 2053129
Book value: 18712055
P/B ratio: 1.1740282026746927
Market cap (USD): 21968480.299999997
Debt to equity: 0
Current ratio: 56.90437077146749
Quick ratio: 56.90437077146749
Effective tax rate (%): 31.242394873130475
COGS to revenue (%): 10.800670903954803
SG&A to revenue (%): 110.93087923728812
Free cash flow (dilution-adjusted): -24638
Buyback yield (%): 0
Retained earnings: 15898934
Receivables turnover: 2.274851060981324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15787148979628374
FCF margin (%): -18.124705743879474
Revenue growth (%): -60.95857362773705
Rule of 40 score: -79.08327937161653
Financial ratios for CKX — quarterly report dated 2025-09-30
Total revenue: 232639
Gross profit: 214048
Operating income: 27165
Net income: 166304
Capital expenditures: 141105
Operating cash flow: 242270
Depreciation & amortization: 837
Net tangible assets: 18878359
Owner earnings: 26036
Return on net tangible assets (%): 0.13791452954147126
Capex to operating income (%): 519.4367752622861
Buffett classification: The Gruesome
Stock price: 11.14
P/E ratio: 51.6389160546285
Shares outstanding: 2053129
Book value: 18878359
P/B ratio: 1.2115384107273308
Market cap (USD): 22871857.060000002
Debt to equity: 0
Current ratio: 52.45231200506585
Quick ratio: 52.45231200506585
Effective tax rate (%): -1.557213869584865
COGS to revenue (%): 7.991351407115746
SG&A to revenue (%): 80.33175864751826
Free cash flow (dilution-adjusted): 242270
Buyback yield (%): 0
Retained earnings: 16065238
Receivables turnover: 5.239499110380397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.14389492222284786
FCF margin (%): 104.13989056005227
Revenue growth (%): 71.13862405838042
Rule of 40 score: 175.27851461843267
Financial ratios for CKX — annual report dated 2025-12-31
Total revenue: 838543
Gross profit: 770736
Operating income: 83295
Net income: 3009972
Capital expenditures: 8368024
Operating cash flow: 459630
Depreciation & amortization: 3235
Net tangible assets: 21445412
Owner earnings: -5354817
Return on net tangible assets (%): -24.969522618637498
Capex to operating income (%): 10046.250075034515
Buffett classification: The Gruesome
Stock price: 9.15
P/E ratio: 6.2412973775171325
Shares outstanding: 2053129
Book value: 21445412
P/B ratio: 0.8759976422929063
Market cap (USD): 18786130.35
Debt to equity: 0
Current ratio: 24.730292359549946
Quick ratio: 24.730292359549946
Effective tax rate (%): 24.31109886219161
COGS to revenue (%): 8.086287763418214
SG&A to revenue (%): 81.98041126096098
Free cash flow (dilution-adjusted): 459630
Buyback yield (%): 0.7857605438152406
Retained earnings: 18632291
Receivables turnover: 20.10653398873037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3864235012293459
FCF margin (%): 54.812931477574786
Revenue growth (%): -44.87346199257917
Rule of 40 score: 9.939469484995612
Financial ratios for CKX — quarterly report dated 2025-12-31
Total revenue: 121784
Gross profit: 112604
Operating income: -26478
Net income: 2567053
Capital expenditures: 7868796
Operating cash flow: 123334
Depreciation & amortization: 711
Net tangible assets: 21445412
Owner earnings: -5301032
Return on net tangible assets (%): -24.718723053676936
Buffett classification: The Gruesome
Stock price: 9.15
P/E ratio: 6.2412973775171325
Shares outstanding: 2053129
Book value: 21445412
P/B ratio: 0.8759976422929063
Market cap (USD): 18786130.35
Debt to equity: 0
Current ratio: 24.730292359549946
Quick ratio: 24.730292359549946
Effective tax rate (%): 23.895198707401313
COGS to revenue (%): 7.5379360178676995
SG&A to revenue (%): 114.20383630033501
Free cash flow (dilution-adjusted): 123334
Buyback yield (%): 0
Retained earnings: 18632291
Receivables turnover: 2.9201294808775926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1228371626814409
FCF margin (%): 101.27274518820207
Revenue growth (%): -47.651081718886346
Rule of 40 score: 53.62166346931572
Financial ratios for CLDT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.96
Shares outstanding: 46681220
Market cap (USD): 558307391.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLDT — annual report dated 2022-12-31
Total revenue: 294851000
Gross profit: 111557000
Operating income: 34185000
Net income: 9871000
Capital expenditures: 0
Operating cash flow: 71535000
Depreciation & amortization: 59350000
Net tangible assets: 794894000
Owner earnings: 69221000
Return on net tangible assets (%): 8.708205119173122
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.76
P/E ratio: 50.88541456792625
Shares outstanding: 46681220
Book value: 817997000
P/B ratio: 0.6140486177822168
Market cap (USD): 502289927.2
Debt to equity: 0.6014594185553248
Current ratio: 1.491333076535601
Quick ratio: 1.491333076535601
Effective tax rate (%): 0
Interest coverage ratio: 1.2922431390337945
COGS to revenue (%): 62.241945932013124
SG&A to revenue (%): 5.880597318645689
Free cash flow (dilution-adjusted): 65984000
Buyback yield (%): 0
Retained earnings: -252665000
Receivables turnover: 56.943028196214755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.609563897101426
FCF margin (%): 22.3787607978267
Rule of 40 score: 22.3787607978267
Financial ratios for CLDT — annual report dated 2023-12-31
Total revenue: 311109000
Gross profit: 110933000
Operating income: 32862000
Net income: 2644000
Capital expenditures: 0
Operating cash flow: 76442000
Depreciation & amortization: 58254000
Net tangible assets: 776061000
Owner earnings: 60898000
Return on net tangible assets (%): 7.847063568456604
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.67
P/E ratio: 170.72897027231468
Shares outstanding: 46681220
Book value: 804376000
P/B ratio: 0.5611895399663839
Market cap (USD): 451407397.4
Debt to equity: 0.6276728793499557
Current ratio: 2.599555799128905
Quick ratio: 2.599555799128905
Effective tax rate (%): 0
Interest coverage ratio: 1.2113683279268652
COGS to revenue (%): 64.41150850666487
SG&A to revenue (%): 5.630502492695486
Free cash flow (dilution-adjusted): 70325000
Buyback yield (%): 0
Retained earnings: -271651000
Receivables turnover: 71.11062857142858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5099655454489214
FCF margin (%): 22.60461767419136
Revenue growth (%): 5.513971463552777
Rule of 40 score: 28.118589137744138
Financial ratios for CLDT — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 15232000
Buffett classification: The Gruesome
Stock price: 7.87
Shares outstanding: 46681220
Market cap (USD): 367381201.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLDT — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 15233000
Buffett classification: The Gruesome
Stock price: 8.33
Shares outstanding: 46681220
Market cap (USD): 388854562.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLDT — annual report dated 2024-12-31
Total revenue: 317209000
Gross profit: 111219000
Operating income: 31763000
Net income: 4166000
Capital expenditures: 700000
Operating cash flow: 73825000
Depreciation & amortization: 60741000
Net tangible assets: 758219000
Owner earnings: 64207000
Return on net tangible assets (%): 8.468133876887812
Capex to operating income (%): 2.2038220571104743
Buffett classification: The Great
Stock price: 8.33
P/E ratio: 93.34002942870859
Shares outstanding: 46681220
Book value: 791997000
P/B ratio: 0.4909798428529401
Market cap (USD): 388854562.6
Debt to equity: 0.5397533071463655
Current ratio: 0.9307974205278259
Quick ratio: 0.9307974205278259
Effective tax rate (%): 0
Interest coverage ratio: 1.0777713684639136
COGS to revenue (%): 65.00698277791614
SG&A to revenue (%): 5.796809043879588
Free cash flow (dilution-adjusted): 66727000
Buyback yield (%): 0
Retained earnings: -289130000
Receivables turnover: 108.59602875727491
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.604634762357726
FCF margin (%): 21.03565787855956
Revenue growth (%): 1.9607275906515078
Rule of 40 score: 22.99638546921107
Financial ratios for CLDT — quarterly report dated 2025-03-31
Total revenue: 68635000
Gross profit: 20835000
Operating income: 1190000
Net income: 1536000
Capital expenditures: 0
Operating cash flow: 4190000
Depreciation & amortization: 15032000
Net tangible assets: 754699000
Owner earnings: 16568000
Return on net tangible assets (%): 2.1953123033156263
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.72
P/E ratio: 51.057584375
Shares outstanding: 46681220
Book value: 788880000
P/B ratio: 0.39764957712199567
Market cap (USD): 313697798.4
Debt to equity: 0.5090305242875977
Current ratio: 0.20847011025569312
Quick ratio: 0.20847011025569312
Effective tax rate (%): 0
Interest coverage ratio: 0.18268345102855388
COGS to revenue (%): 69.71807386901726
SG&A to revenue (%): 6.710861805201428
Free cash flow (dilution-adjusted): 2583000
Buyback yield (%): 0.0015938906889057722
Retained earnings: -293990000
Receivables turnover: 21.900127632418634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.10912985902989975
FCF margin (%): 3.763386027536971
Rule of 40 score: 3.763386027536971
Financial ratios for CLDT — quarterly report dated 2025-06-30
Total revenue: 80294000
Gross profit: 30891000
Operating income: 11504000
Net income: 5499000
Capital expenditures: 0
Operating cash flow: 22062000
Depreciation & amortization: 15395000
Net tangible assets: 754090000
Owner earnings: 20894000
Return on net tangible assets (%): 2.7707568062167645
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.65
P/E ratio: 44.126526368159205
Shares outstanding: 46681220
Book value: 788969000
P/B ratio: 0.3934630042498502
Market cap (USD): 310430113
Debt to equity: 0.47095386510750104
Current ratio: 0.854788115530303
Quick ratio: 0.854788115530303
Effective tax rate (%): 0
Interest coverage ratio: 1.8921052631578947
COGS to revenue (%): 61.58990709143897
SG&A to revenue (%): 4.971728896306075
Free cash flow (dilution-adjusted): 20505000
Buyback yield (%): 0.04638725238617556
Retained earnings: -295014000
Receivables turnover: 17.171514114627886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9912652504831815
FCF margin (%): 25.537400054798614
Revenue growth (%): 16.98696000582793
Rule of 40 score: 42.52436006062655
Financial ratios for CLDT — quarterly report dated 2025-09-30
Total revenue: 78409000
Gross profit: 28759000
Operating income: 9894000
Net income: 3587000
Capital expenditures: 0
Operating cash flow: 25574000
Depreciation & amortization: 14707000
Net tangible assets: 749440000
Owner earnings: 18294000
Return on net tangible assets (%): 2.4410226302305724
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.49
P/E ratio: 28.52204083976652
Shares outstanding: 46681220
Book value: 785483000
P/B ratio: 0.3857004133762284
Market cap (USD): 302961117.8
Debt to equity: 0.45711619474896337
Current ratio: 0.6653684210526316
Quick ratio: 0.6653684210526316
Effective tax rate (%): 0
Interest coverage ratio: 1.6775178026449644
COGS to revenue (%): 63.3855807369052
SG&A to revenue (%): 5.282556849341274
Free cash flow (dilution-adjusted): 23918000
Buyback yield (%): 0.6046980593758556
Retained earnings: -297857000
Receivables turnover: 20.032958610117525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8644520942911562
FCF margin (%): 30.50415130916094
Revenue growth (%): -2.3476224873589557
Rule of 40 score: 28.156528821801984
Financial ratios for CLDT — annual report dated 2025-12-31
Total revenue: 295075000
Gross profit: 102872000
Operating income: 26507000
Net income: 15313000
Capital expenditures: 110000
Operating cash flow: 64078000
Depreciation & amortization: 59749000
Net tangible assets: 740802000
Owner earnings: 74952000
Return on net tangible assets (%): 10.11768326759377
Capex to operating income (%): 0.4149847210170898
Buffett classification: The Great
Stock price: 6.67
P/E ratio: 20.33329441650885
Shares outstanding: 46681220
Book value: 778049000
P/B ratio: 0.4001852549132509
Market cap (USD): 311363737.4
Debt to equity: 0.46138482280678983
Current ratio: 1.063474454305589
Quick ratio: 1.063474454305589
Effective tax rate (%): 0
Interest coverage ratio: 1.096191224515115
COGS to revenue (%): 65.20410065237652
SG&A to revenue (%): 5.6219605185122425
Free cash flow (dilution-adjusted): 57712000
Buyback yield (%): 2.8815173131333314
Retained earnings: -299527000
Receivables turnover: 104.22995407983045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.331251005911019
FCF margin (%): 19.5584173515208
Revenue growth (%): -6.977733923060191
Rule of 40 score: 12.580683428460608
Financial ratios for CLDT — quarterly report dated 2025-12-31
Total revenue: 67738000
Gross profit: 22387000
Operating income: 3920000
Net income: 4709000
Capital expenditures: 0
Operating cash flow: 12252000
Depreciation & amortization: 14616000
Net tangible assets: 740802000
Owner earnings: 19325000
Return on net tangible assets (%): 2.6086592638788773
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.67
P/E ratio: 20.309421264105406
Shares outstanding: 46681220
Book value: 778049000
P/B ratio: 0.4001852549132509
Market cap (USD): 311363737.4
Debt to equity: 0.46138482280678983
Current ratio: 1.063474454305589
Quick ratio: 1.063474454305589
Effective tax rate (%): 0
Interest coverage ratio: 0.6889279437609842
COGS to revenue (%): 67.02146505654139
SG&A to revenue (%): 5.680710974637574
Free cash flow (dilution-adjusted): 10706000
Buyback yield (%): 2.245283942946402
Retained earnings: -299527000
Receivables turnover: 23.927234192864713
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3447581372154976
FCF margin (%): 15.805013434113791
Revenue growth (%): -13.609407083370531
Rule of 40 score: 2.19560635074326
Financial ratios for CLM.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.03937007874015748
Shares outstanding: 546822265
Market cap (USD): 21528435.62992126
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLM.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -18861.764705882353
Operating income: -3965468.3823529407
Net income: -3123694.117647059
Capital expenditures: 62499.99999999999
Operating cash flow: -3163774.264705882
Depreciation & amortization: 18861.764705882353
Net tangible assets: 1664807.3529411764
Owner earnings: -3167332.3529411764
Return on net tangible assets (%): -190.25218427498677
Buffett classification: The Gruesome
Stock price: 0.058823529411764705
Shares outstanding: 546822265
Book value: 1664807.3529411764
P/B ratio: 19.32116381598648
Market cap (USD): 32166015.588235293
Debt to equity: 0.08091158754457546
Current ratio: 3.260394535896307
Quick ratio: 3.260394535896307
Interest coverage ratio: -606.6408323959505
Free cash flow (dilution-adjusted): -3656486.0294117643
Buyback yield (%): 0
Retained earnings: -19205072.794117644
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -224.52464217020963
Rule of 40 score: 0
Financial ratios for CLM.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -58666.666666666664
Operating income: -4452506.818181818
Net income: -4122028.7878787876
Capital expenditures: 0
Operating cash flow: -3731725
Depreciation & amortization: 58666.666666666664
Net tangible assets: 2081638.6363636362
Owner earnings: -4063362.121212121
Return on net tangible assets (%): -195.20016828234458
Buffett classification: The Gruesome
Stock price: 0.022727272727272724
Shares outstanding: 546822265
Book value: 2081638.6363636365
P/B ratio: 5.970190278419207
Market cap (USD): 12427778.749999998
Debt to equity: 0.05016480679010526
Current ratio: 10.431879518756835
Quick ratio: 10.431879518756835
Interest coverage ratio: -327.93823234014064
Free cash flow (dilution-adjusted): -4024531.0606060605
Buyback yield (%): 0
Retained earnings: -23238297.727272727
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -207.23960568364498
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007407407407407407
Shares outstanding: 546822265
Market cap (USD): 4050535.296296296
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLM.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -67288.81118881119
Operating income: -1927681.118881119
Net income: -1905709.7902097902
Capital expenditures: 0
Operating cash flow: -1701444.7552447554
Depreciation & amortization: 67288.81118881119
Net tangible assets: 369379.7202797203
Owner earnings: -1838420.979020979
Return on net tangible assets (%): -497.7049031356668
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 546822265
Book value: 369379.72027972026
P/B ratio: 10.352306077283218
Market cap (USD): 3823931.9230769235
Debt to equity: 0
Current ratio: 4.177049062005666
Quick ratio: 4.177049062005666
Interest coverage ratio: -257.48029142536893
Free cash flow (dilution-adjusted): -1848276.223776224
Buyback yield (%): 0
Retained earnings: -23073462.937062938
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -521.8697760183866
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -26588.11188811189
Operating income: 67551.04895104896
Net income: 73251.74825174826
Capital expenditures: 0
Operating cash flow: -178534.26573426573
Depreciation & amortization: 26588.11188811189
Net tangible assets: 369379.7202797203
Owner earnings: 99839.86013986015
Return on net tangible assets (%): 27.029058353353662
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.006993006993006994
P/E ratio: 13.050650715990454
Shares outstanding: 546822265
Book value: 369379.72027972026
P/B ratio: 10.352306077283218
Market cap (USD): 3823931.9230769235
Debt to equity: 0
Current ratio: 4.177049062005666
Quick ratio: 4.177049062005666
Interest coverage ratio: 56.655718475073314
Free cash flow (dilution-adjusted): -204502.7972027972
Buyback yield (%): 0
Retained earnings: -23073462.937062938
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.287698333816095
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -140372.72727272726
Net income: -139934.26573426573
Capital expenditures: 0
Operating cash flow: -52263.63636363637
Depreciation & amortization: 0
Net tangible assets: 245239.16083916085
Owner earnings: -139934.26573426573
Return on net tangible assets (%): -57.060326440295185
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 546822265
Book value: 245239.16083916085
P/B ratio: 15.592664360749604
Market cap (USD): 3823931.9230769235
Debt to equity: 0
Current ratio: 2.981993794471541
Quick ratio: 2.981993794471541
Interest coverage ratio: -988.8325123152707
Free cash flow (dilution-adjusted): -68057.34265734267
Buyback yield (%): 0
Retained earnings: -23213397.202797204
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -57.23911580532205
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -237890.51094890508
Net income: -237524.08759124085
Capital expenditures: 0
Operating cash flow: 9293.430656934306
Depreciation & amortization: 0
Net tangible assets: 180560.58394160582
Owner earnings: -237524.08759124085
Return on net tangible assets (%): -131.54813880534266
Buffett classification: The Gruesome
Stock price: 0.0072992700729927005
Shares outstanding: 546822265
Book value: 180560.58394160584
P/B ratio: 22.105618552116685
Market cap (USD): 3991403.3941605836
Debt to equity: 0
Current ratio: 2.031095253180386
Quick ratio: 2.031095253180386
Interest coverage ratio: -1410.8658008658008
Free cash flow (dilution-adjusted): 35.03649635036527
Buyback yield (%): 0
Retained earnings: -24120483.941605836
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -131.75107532097925
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -167256.8345323741
Net income: -166746.04316546765
Capital expenditures: 0
Operating cash flow: -127508.63309352519
Depreciation & amortization: 0
Net tangible assets: 16954.676258992808
Owner earnings: -166746.04316546765
Return on net tangible assets (%): -983.4811388806382
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
Shares outstanding: 546822265
Book value: 16954.67625899281
P/B ratio: 696.0863898671869
Market cap (USD): 11801919.38848921
Debt to equity: 0
Current ratio: 1.1062756185657663
Quick ratio: 1.1062756185657663
Interest coverage ratio: -1519.5228758169935
Free cash flow (dilution-adjusted): -133247.4820143885
Buyback yield (%): 0
Retained earnings: -23905541.726618707
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -986.4519687712149
Rule of 40 score: 0
Financial ratios for CLM.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -1049408.7591240874
Net income: -1046883.2116788321
Capital expenditures: 0
Operating cash flow: -800022.6277372262
Depreciation & amortization: 0
Net tangible assets: 2139188.321167883
Owner earnings: -1046883.2116788321
Return on net tangible assets (%): -48.93833802847659
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 546822265
Book value: 2139188.321167883
P/B ratio: 9.329247347380548
Market cap (USD): 19957016.970802918
Debt to equity: 0
Current ratio: 13.491268125517173
Quick ratio: 13.491268125517173
Interest coverage ratio: -1707.4703087885985
Free cash flow (dilution-adjusted): -846848.1751824816
Buyback yield (%): 0
Retained earnings: -24729557.664233577
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.056399043501045
Rule of 40 score: 0
Financial ratios for CLM.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -495299.27007299266
Net income: -494116.05839416053
Capital expenditures: 0
Operating cash flow: -625393.4306569343
Depreciation & amortization: 0
Net tangible assets: 2139188.321167883
Owner earnings: -494116.05839416053
Return on net tangible assets (%): -23.09829637272886
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 546822265
Book value: 2139188.321167883
P/B ratio: 9.329247347380548
Market cap (USD): 19957016.970802918
Debt to equity: 0
Current ratio: 13.491268125517173
Quick ratio: 13.491268125517173
Interest coverage ratio: -2661.0196078431372
Free cash flow (dilution-adjusted): -640652.5547445255
Buyback yield (%): 0
Retained earnings: -24729557.664233577
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.153607617051016
Rule of 40 score: 0
Financial ratios for CMI — annual report dated 2021-12-31
Capital expenditures: 20000000
Buffett classification: The Gruesome
Stock price: 196.47
Shares outstanding: 137989067
Market cap (USD): 27110711993.49
Buyback yield (%): 5.171387606259317
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMI — annual report dated 2022-12-31
Total revenue: 28074000000
Gross profit: 6719000000
Operating income: 2580000000
Net income: 2183000000
Capital expenditures: 916000000
Operating cash flow: 1962000000
Depreciation & amortization: 784000000
Net tangible assets: 3945000000
Owner earnings: 2051000000
Return on net tangible assets (%): 51.98986058301648
Capex to operating income (%): 35.50387596899225
Buffett classification: The Good
Stock price: 224.15
P/E ratio: 14.16868958683005
Shares outstanding: 137989067
Book value: 10225000000
P/B ratio: 3.024963263378973
Market cap (USD): 30930249368.05
Debt to equity: 0.8171149144254278
Current ratio: 1.2653007617546626
Quick ratio: 0.7747132475264863
Effective tax rate (%): 22.561191912025542
Interest coverage ratio: 12.964824120603016
COGS to revenue (%): 76.06682339531238
R&D to revenue (%): 4.552254755289592
SG&A to revenue (%): 9.571133433069743
Free cash flow (dilution-adjusted): 1046000000
Buyback yield (%): 1.2091722751719245
Retained earnings: 18037000000
Inventory turnover: 3.8113510619311084
Receivables turnover: 5.3967704728950405
Capitalized R&D asset: 1278000000
ROCI (R&D-adjusted, %): 17.02718793411391
FCF margin (%): 3.725867350573484
Rule of 40 score: 3.725867350573484
Financial ratios for CMI — annual report dated 2023-12-31
Total revenue: 34065000000
Gross profit: 8249000000
Operating income: 1278000000
Net income: 840000000
Capital expenditures: 1213000000
Operating cash flow: 3966000000
Depreciation & amortization: 1024000000
Net tangible assets: 3832000000
Owner earnings: 651000000
Return on net tangible assets (%): 16.988517745302715
Capex to operating income (%): 94.91392801251956
Buffett classification: The Gruesome
Stock price: 228
P/E ratio: 37.45417532857143
Shares outstanding: 137989067
Book value: 9904000000
P/B ratio: 3.176646534329564
Market cap (USD): 31461507276
Debt to equity: 0.7277867528271406
Current ratio: 1.1778656126482214
Quick ratio: 0.7378904130822289
Effective tax rate (%): 48.33948339483395
Interest coverage ratio: 3.408
COGS to revenue (%): 75.78452957581095
R&D to revenue (%): 4.4033465433729635
SG&A to revenue (%): 9.784236019374724
Free cash flow (dilution-adjusted): 2753000000
Buyback yield (%): 0
Retained earnings: 17851000000
Inventory turnover: 4.5474722564734895
Receivables turnover: 6.101558301988178
Capitalized R&D asset: 2356260000
ROCI (R&D-adjusted, %): 8.630709106889375
Rosenberg metric: 1.1971830985915493
FCF margin (%): 8.081608689270512
Revenue growth (%): 21.34002992092327
Rule of 40 score: 29.42163861019378
Financial ratios for CMI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 313.83
Shares outstanding: 137989067
Market cap (USD): 43305108896.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 339.55
Shares outstanding: 137989067
Market cap (USD): 46854187699.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMI — annual report dated 2024-12-31
Total revenue: 34102000000
Gross profit: 8439000000
Operating income: 3372000000
Net income: 4068000000
Capital expenditures: 1208000000
Operating cash flow: 1487000000
Depreciation & amortization: 1065000000
Net tangible assets: 5550000000
Owner earnings: 3925000000
Return on net tangible assets (%): 70.72072072072072
Capex to operating income (%): 35.82443653618031
Buffett classification: The Good
Stock price: 339.55
P/E ratio: 11.51774525561701
Shares outstanding: 137989067
Book value: 11308000000
P/B ratio: 4.143454872643261
Market cap (USD): 46854187699.85
Debt to equity: 0.671913689423417
Current ratio: 1.3131564892291259
Quick ratio: 0.8020295531422468
Effective tax rate (%): 17.030389557413827
Interest coverage ratio: 9.113513513513514
COGS to revenue (%): 75.25365081226909
R&D to revenue (%): 4.290070963579849
SG&A to revenue (%): 9.603542314233769
Free cash flow (dilution-adjusted): 279000000
Buyback yield (%): 0
Retained earnings: 20828000000
Inventory turnover: 4.469348659003831
Receivables turnover: 6.582127002509168
Capitalized R&D asset: 2889740000
ROCI (R&D-adjusted, %): 14.749834811622017
Rosenberg metric: 0.12666666666666668
FCF margin (%): 0.8181338337927394
Revenue growth (%): 0.10861588140319976
Rule of 40 score: 0.9267497151959392
Financial ratios for CMI — quarterly report dated 2025-03-31
Total revenue: 8174000000
Gross profit: 2155000000
Operating income: 1003000000
Net income: 850000000
Capital expenditures: 162000000
Operating cash flow: -3000000
Depreciation & amortization: 269000000
Net tangible assets: 6126000000
Owner earnings: 957000000
Return on net tangible assets (%): 15.621939275220372
Capex to operating income (%): 16.151545363908276
Buffett classification: The Great
Stock price: 306.75
P/E ratio: 12.449454794779411
Shares outstanding: 137989067
Book value: 11971000000
P/B ratio: 3.535890594123298
Market cap (USD): 42328146302.25
Debt to equity: 0.6712054130816139
Current ratio: 1.342548596112311
Quick ratio: 0.8135637149028078
Effective tax rate (%): 23.903312444046556
Interest coverage ratio: 13.025974025974026
COGS to revenue (%): 73.63591876682163
R&D to revenue (%): 4.2084658673843895
SG&A to revenue (%): 9.432346464399314
Free cash flow (dilution-adjusted): -165000000
Buyback yield (%): 0
Retained earnings: 21401000000
Inventory turnover: 0.9830148619957537
Receivables turnover: 1.4390845070422535
Capitalized R&D asset: 344000000
ROCI (R&D-adjusted, %): 5.785602503912362
FCF margin (%): -2.0185955468558845
Rule of 40 score: -2.0185955468558845
Financial ratios for CMI — quarterly report dated 2025-06-30
Total revenue: 8643000000
Gross profit: 2281000000
Operating income: 1108000000
Net income: 928000000
Capital expenditures: 231000000
Operating cash flow: 785000000
Depreciation & amortization: 279000000
Net tangible assets: 6961000000
Owner earnings: 976000000
Return on net tangible assets (%): 14.020973997988795
Capex to operating income (%): 20.848375451263536
Buffett classification: The Great
Stock price: 322.34
P/E ratio: 25.016533102800896
Shares outstanding: 137989067
Book value: 12873000000
P/B ratio: 3.455247095221005
Market cap (USD): 44479395856.78
Debt to equity: 0.6745902276081721
Current ratio: 1.6415899175957345
Quick ratio: 1.0320891904992728
Effective tax rate (%): 24.24489795918367
Interest coverage ratio: 12.735632183908047
COGS to revenue (%): 73.60870068263334
R&D to revenue (%): 4.130510239500174
SG&A to revenue (%): 9.013074164063402
Free cash flow (dilution-adjusted): 554000000
Buyback yield (%): 0
Retained earnings: 22040000000
Inventory turnover: 1.011929378081756
Receivables turnover: 1.4713993871297242
Capitalized R&D asset: 587480000
ROCI (R&D-adjusted, %): 5.019400922134879
Rosenberg metric: 0.36627906976744184
FCF margin (%): 6.4098114080759
Revenue growth (%): 5.737704918032787
Rule of 40 score: 12.147516326108686
Financial ratios for CMI — quarterly report dated 2025-09-30
Total revenue: 8317000000
Gross profit: 2129000000
Operating income: 962000000
Net income: 559000000
Capital expenditures: 298000000
Operating cash flow: 1305000000
Depreciation & amortization: 277000000
Net tangible assets: 7497000000
Owner earnings: 538000000
Return on net tangible assets (%): 7.176203814859278
Capex to operating income (%): 30.97713097713098
Buffett classification: The Good
Stock price: 417.83
P/E ratio: 24.6709336177193
Shares outstanding: 137989067
Book value: 13098000000
P/B ratio: 4.401891270774928
Market cap (USD): 57655971864.61
Debt to equity: 0.6246755229806077
Current ratio: 1.7685635709752485
Quick ratio: 1.1068330865242226
Effective tax rate (%): 32.65060240963855
Interest coverage ratio: 11.590361445783133
COGS to revenue (%): 74.40182758206085
R&D to revenue (%): 4.1481303354574965
SG&A to revenue (%): 9.486593723698448
Free cash flow (dilution-adjusted): 1007000000
Buyback yield (%): 0
Retained earnings: 22300000000
Inventory turnover: 0.9891304347826086
Receivables turnover: 1.474645390070922
Capitalized R&D asset: 697710000
ROCI (R&D-adjusted, %): 3.8515573621480725
Rosenberg metric: -0.4257703081232493
FCF margin (%): 12.107731153059998
Revenue growth (%): -3.7718384820085618
Rule of 40 score: 8.335892671051436
Financial ratios for CMI — annual report dated 2025-12-31
Total revenue: 33670000000
Gross profit: 8516000000
Operating income: 3865000000
Net income: 2957000000
Capital expenditures: 1235000000
Operating cash flow: 3621000000
Depreciation & amortization: 1105000000
Net tangible assets: 7958000000
Owner earnings: 2827000000
Return on net tangible assets (%): 35.524001005277704
Capex to operating income (%): 31.953428201811125
Buffett classification: The Good
Stock price: 507.15
P/E ratio: 23.66626828848495
Shares outstanding: 137989067
Book value: 13408000000
P/B ratio: 5.219358243515066
Market cap (USD): 69981155329.05
Debt to equity: 0.6051610978520287
Current ratio: 1.7611862643080125
Quick ratio: 1.1553590010405828
Effective tax rate (%): 25.384809487761796
Interest coverage ratio: 11.74772036474164
COGS to revenue (%): 74.70745470745472
R&D to revenue (%): 4.146124146124146
SG&A to revenue (%): 9.281259281259281
Free cash flow (dilution-adjusted): 2386000000
Buyback yield (%): 0
Retained earnings: 22616000000
Inventory turnover: 4.320508416351769
Receivables turnover: 5.787212100378137
Capitalized R&D asset: 2871210000
ROCI (R&D-adjusted, %): 13.9726659721919
Rosenberg metric: 0.05263157894736842
FCF margin (%): 7.086427086427087
Revenue growth (%): -1.2667878716790804
Rule of 40 score: 5.8196392147480065
Financial ratios for CMI — quarterly report dated 2025-12-31
Total revenue: 8536000000
Gross profit: 1951000000
Operating income: 781000000
Net income: 620000000
Capital expenditures: 544000000
Operating cash flow: 1534000000
Depreciation & amortization: 280000000
Net tangible assets: 7958000000
Owner earnings: 356000000
Return on net tangible assets (%): 4.473485800452375
Capex to operating income (%): 69.65428937259924
Buffett classification: The Good
Stock price: 507.15
P/E ratio: 23.66626828848495
Shares outstanding: 137989067
Book value: 13408000000
P/B ratio: 5.219358243515066
Market cap (USD): 69981155329.05
Debt to equity: 0.6051610978520287
Current ratio: 1.7611862643080125
Quick ratio: 1.1553590010405828
Effective tax rate (%): 21.61820480404551
Interest coverage ratio: 9.524390243902438
COGS to revenue (%): 77.14386129334582
R&D to revenue (%): 4.100281162136833
SG&A to revenue (%): 9.208059981255857
Free cash flow (dilution-adjusted): 990000000
Buyback yield (%): 0
Retained earnings: 22616000000
Inventory turnover: 1.131054620405359
Receivables turnover: 1.467170849089034
Capitalized R&D asset: 698960000
ROCI (R&D-adjusted, %): 3.1112578359573684
Rosenberg metric: -0.5159420289855072
FCF margin (%): 11.597938144329897
Revenue growth (%): 2.6331609955512807
Rule of 40 score: 14.231099139881177
Financial ratios for CMIG4.SA — annual report dated 2021-12-31
Operating income: 1247935368.043088
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7298245614035088
Shares outstanding: 1904080104
Market cap (USD): 1389644426.7789474
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMIG4.SA — annual report dated 2022-12-31
Total revenue: 8275757575.757575
Gross profit: 786742424.2424242
Operating income: 665909090.9090909
Net income: 775378787.8787879
Capital expenditures: 32765151.515151512
Operating cash flow: 1239393939.3939393
Depreciation & amortization: 223863636.36363634
Net tangible assets: 1355492424.2424242
Owner earnings: 966477272.7272727
Return on net tangible assets (%): 71.30082436775184
Capex to operating income (%): 4.920364050056882
Buffett classification: The Great
Stock price: 1.0436432637571158
P/E ratio: 2.562851093244244
Shares outstanding: 1904080104
Book value: 4125757575.757575
P/B ratio: 0.4816522390627037
Market cap (USD): 1987180374.1935484
Debt to equity: 0.5019739258171135
Current ratio: 1.2019102026242972
Quick ratio: 1.2019102026242972
Effective tax rate (%): 0.6310679611650485
Interest coverage ratio: 3.788793103448276
COGS to revenue (%): 63.280391797876234
SG&A to revenue (%): 3.233705602343464
Free cash flow (dilution-adjusted): 1184090909.090909
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 5.24247150569886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.27917490816615
FCF margin (%): 14.307945807396557
Rule of 40 score: 14.307945807396557
Financial ratios for CMIG4.SA — annual report dated 2023-12-31
Total revenue: 9381443298.969072
Gross profit: 1728659793.814433
Operating income: 1281030927.8350515
Net income: 1189072164.9484537
Capital expenditures: 221855670.1030928
Operating cash flow: 1370309278.3505156
Depreciation & amortization: 262680412.37113404
Net tangible assets: 1938556701.030928
Owner earnings: 1229896907.216495
Return on net tangible assets (%): 63.44394809614976
Capex to operating income (%): 17.31852567197811
Buffett classification: The Great
Stock price: 1.31055900621118
P/E ratio: 2.0986189084267197
Shares outstanding: 1904080104
Book value: 5083711340.206185
P/B ratio: 0.4908636942284593
Market cap (USD): 2495409328.8447204
Debt to equity: 0.4162881245944193
Current ratio: 0.9065149316428627
Quick ratio: 0.9065149316428627
Effective tax rate (%): 15.822507663114871
Interest coverage ratio: 6.133267522211253
COGS to revenue (%): 62.562637362637375
SG&A to revenue (%): 3.1384615384615384
Free cash flow (dilution-adjusted): 1109690721.6494846
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 6.1653116531165315
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.82568544634548
FCF margin (%): 11.82857142857143
Revenue growth (%): 13.36053784913197
Rule of 40 score: 25.189109277703402
Financial ratios for CMIG4.SA — quarterly report dated 2024-09-30
Total revenue: 2304351565.3775325
Gross profit: 288154696.1325967
Net income: 604087845.3038675
Capital expenditures: 680847145.4880295
Operating cash flow: 853959484.3462247
Depreciation & amortization: 186372007.36648253
Net tangible assets: 2183241252.302026
Owner earnings: 109612707.18232048
Return on net tangible assets (%): 5.020641079713203
Buffett classification: The Gruesome
Stock price: 1.6703499079189688
P/E ratio: 1.3162324201320834
Shares outstanding: 1904080104
Book value: 5168324125.230203
P/B ratio: 0.6153793665649943
Market cap (USD): 3180480026.3867407
Debt to equity: 0.5185647092360319
Current ratio: 1.0432106680343634
Quick ratio: 1.0432106680343634
Effective tax rate (%): 27.917580461563478
COGS to revenue (%): 67.8555561744858
SG&A to revenue (%): 1.650716248359957
Free cash flow (dilution-adjusted): 154511970.53407
Buyback yield (%): 0
Retained earnings: 892633517.495396
Receivables turnover: 1.7839505275163958
Capitalized R&D asset: 0
FCF margin (%): 6.705225576495555
Rule of 40 score: 6.705225576495555